Back

Evaluation of antiretroviral therapy on metabolomics and atherogenic markers in HIV patients

31 August 2020 (08:30 - 08:30)
Organised by:
Congress Presentation Part of: Inflammatory and Infectious Disorders and Heart Disease HIV and Cardiovascular Disease ESC Premium Access ESC Congress 2020

About the speaker

Photo
Doctor Miguel Frias

University hospitals of Geneva, Geneva (Switzerland)

5 More presentations in this session

Presentation thumbnail
Genetically rheumatoid arthrits and risk of comorbidities: a Mendelian randomization study
Ms A. Fokina (Vienna, AT)
Abstract Slides
Presentation thumbnail
Predictors of subclinical right ventricular dysfunction and pulmonary hypertension in asymptomatic patients with pulmonary sarcoidosis
Doctor I. Evsikova (Saint Petersburg, RU)
Abstract Slides
Presentation thumbnail
Survey of cardiovascular disease and risk factor management in patients with rheumatoid arthritis across 5 world regions: Results from the SURF-RA
Assistant Professor A. Semb (Oslo, NO)
Abstract Slides
Presentation thumbnail
Can quantitative 18F-FDG PET/CT and serum cytokine analysis differentiate ARVC from cardiac sarcoidosis?
Doctor H. Abbas (Aberdeen, GB)
Abstract Slides
Presentation thumbnail
The systemic immune-inflammation index is associated with early postoperative morbidity and mortality following cardiac surgery
Doctor R. Rosalia (Skopje, MK)
Abstract Slides

Access the full session

Session thumbnail
Inflammatory and Infectious Disorders and Heart Disease

The Event

Event poster

ESC Congress 2020

31 August 2020 08:30 CET
You may be interested in
thumbnail
Congress Presentation
Endothelial glycocalyx improvement after six months and one-year of antiretroviral therapy in treatment naive patients with human immunodeficiency virus
26 August 2022
thumbnail
Congress Presentation
Autoantibodies directed against apolipoprotein-a-1 as a potential contributor to non-alcoholic fatty liver disease
27 August 2021
thumbnail
Congress Presentation
The effect of atorvastatin on mevalonate levels in blood plasma in patients with coronary heart disease and muscle side effects
25 April 2024
thumbnail
Congress Presentation
Lipidomic, plasma and flow cytometry signatures enhance the classification of patients with advanced CVD and CKM syndrome
1 September 2025

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources